Amelioration of diabetes-induced cavernosal fibrosis by antioxidant and anti-transforming growth factor-β1 therapies in inducible nitric oxide synthase-deficient mice.
Amelioration of diabetes-induced cavernosal fibrosis by antioxidant and anti-transforming growth factor-β1 therapies in inducible nitric oxide synthase-deficient mice.
复制标题
DOI:
10.1111/j.1464-410x.2011.10397.x
复制
发表时间:
2012-02
影响因子:
4.5
通讯作者:
Gonzalez-Cadavid NF
中科院分区:
文献类型:
--
作者:
Ferrini MG;Moon J;Rivera S;Rajfer J;Gonzalez-Cadavid NF
To investigate whether sustained long-term separate treatments of diabetic inducible nitric oxide synthase knockout (iNOSKo) mice with allopurinol, an antioxidant inhibiting xanthine oxidoreductase, decorin, a transforming growth factor-β1 (TGFβ1) -binding antagonist, and molsidomine, a long-life nitric oxide donor, prevent the processes of diabetes-induced cavernosal fibrosis. iNOSKo mice were divided into groups and treated Blood chemistry and histopathology were investigated. Eight-week treatment with either allopurinol or decorin counteracted the decrease in smooth muscle cells and the increase in apoptosis and local oxidative stress within the corpora tissue. Decorin but not allopurinol increased the smooth muscle cell/collagen ratio, whereas allopurinol but not decorin inhibited systemic oxidative stress. Molsidomine was effective in reducing both local and systemic oxidative stress, but did not prevent corporal fibrosis. Both allopurinol and decorin appear as promising approaches either as a single or a combined pharmacological modality for protecting the diabetic corpora from undergoing apoptosis and fibrosis although their functional effects still need to be defined.